» Articles » PMID: 39394067

The 95% Effective Dose of Dexmedetomidine to Induce Adequate Sedation in Patients with Chronic Insomnia Disorder: a Biased Coin Design Up-and-down Sequential Allocation Trial

Overview
Journal BMC Anesthesiol
Publisher Biomed Central
Specialty Anesthesiology
Date 2024 Oct 11
PMID 39394067
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic insomnia disorder is a common sleep disorder. Previous studies have reported increased demand for anesthetics in patients with chronic insomnia disorder. However, few studies have investigated the effective dose of dexmedetomidine for sedation in patients with chronic insomnia disorder. We aimed to determine the 95% effective dose of dexmedetomidine to induce adequate sedation in patients with chronic insomnia disorder.

Methods: This is a biased coin design up-and-down sequential allocation trial in patients aged 18-65 years with chronic insomnia disorder (n = 60). The dose of dexmedetomidine for the subsequent patient was determined based on the response of the previous patient, with an interval of 0.1 µg/kg. Sedation was assessed using the bispectral index. The 95% effective dose was calculated using isotonic regression.

Results: The 95% effective dose of dexmedetomidine to induce adequate sedation in patients with chronic insomnia disorder was 1.75 (95% confidence interval, 1.70-1.94) µg/kg. Four patients (6.7%) experienced bradycardia and no other adverse events were observed during the study.

Conclusions: The 95% effective dose of dexmedetomidine to induce adequate sedation in patients with chronic insomnia disorder was 1.75 µg/kg.

Trials Registration: Chinese Clinical Trial Registry (ChiCTR2200063212); first registered 01/09 /2022.

References
1.
Demiri M, Antunes T, Fletcher D, Martinez V . Perioperative adverse events attributed to α2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis. Br J Anaesth. 2019; 123(6):795-807. DOI: 10.1016/j.bja.2019.07.029. View

2.
Wichniak A, Wierzbicka A, Walecka M, Jernajczyk W . Effects of Antidepressants on Sleep. Curr Psychiatry Rep. 2017; 19(9):63. PMC: 5548844. DOI: 10.1007/s11920-017-0816-4. View

3.
Ohayon M, Reynolds 3rd C . Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med. 2009; 10(9):952-60. PMC: 3715324. DOI: 10.1016/j.sleep.2009.07.008. View

4.
Aldrete J, Kroulik D . A postanesthetic recovery score. Anesth Analg. 1970; 49(6):924-34. View

5.
Morin C, Benca R . Chronic insomnia. Lancet. 2012; 379(9821):1129-41. DOI: 10.1016/S0140-6736(11)60750-2. View